Shareholding14 May 2026, 08:45 am
Aptus Pharma: Kripaliben Thakker Increases Stake to 8.64%
AI Summary
Kripaliben Mayank Thakker acquired 18,000 shares of Aptus Pharma Ltd on May 11, 2026, increasing her stake from 8.38% to 8.64%. This acquisition falls under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011. The company's equity share capital remains at 68,60,000 shares of ₹10 each after the acquisition.
Key Highlights
- Kripaliben Mayank Thakker acquired 18,000 shares of Aptus Pharma.
- Her shareholding increased from 8.38% to 8.64%.
- The acquisition was executed on May 11, 2026.
- The company's equity share capital is 68,60,000 shares of ₹10 each.
Price Impact
More from APPL